TP53 and cancer: While admittedly very speculative, we suggest that given these findings, perhaps then naturally occurring variations in the level of p53 protein in the human population may influence the likelihood that a spontaneously arising KRAS mutation initiates tumorigenesis, which may find value in predicting susceptibility to KRAS-driven cancers or in development of therapeutic strategies against KRAS-induced cancers.